Prevention of SCC Risk by Early Treatment of AK

Actinic keratoses (AK) are common and the prevalence continues to increase. There is a small risk of malignant transformation and the goal of this CME is to educate physicians and dermatologists on how to differentiate higher risk disease using current evidence-based literature and to provide latest clinical strategies in managing AK in order to reduce future neoplastic risk.